Cases 21 - 30 of 356
ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al
as 3:2023cv01876
Plaintiff:
ARBUTUS PHARMA CORP. and GENEVANT SCIENCES GMBH
Defendant:
PFIZER INC. and BIONTECH SE
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al
as 2:2023cv01876
Plaintiff:
ARBUTUS PHARMA CORP. and GENEVANT SCIENCES GMBH
Defendant:
PFIZER INC. and BIONTECH SE
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Pfizer Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv01501
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V. and others
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Sinotherapeutics Inc.
as 1:2022cv01484
Plaintiff:
Pfizer Inc., PF Prism C.V., PBG Puerto Rico LLC and others
Counter Defendant:
C.P. Pharmaceuticals International C.V.
Defendant:
Sinotherapeutics Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ModernaTX, Inc. et al v. Pfizer Inc. et al
as 1:2022cv11378
Plaintiff:
ModernaTX, Inc. and Moderna US, Inc.
Defendant:
Pfizer Inc., BioNTech SE, BioNTech Manufacturing GmbH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BioNTech SE et al v. CureVac AG
as 1:2022cv11202
Plaintiff:
BioNTech SE, BioNTech Manufacturing GmbH and Pfizer, Inc.
Defendant:
CureVac AG
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgment
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al
as 1:2022cv00924
Plaintiff:
Alnylam Pharmaceuticals, Inc.
Defendant:
Pfizer Inc., Pharmacia & Upjohn Co. LLC, BioNTech SE and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Enanta Pharmaceuticals, Inc. v. Pfizer Inc.
as 1:2022cv10967
Plaintiff:
Enanta Pharmaceuticals, Inc.
Defendant:
Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. MSN Laboratories Private Ltd.
as 1:2022cv00746
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF Prism C.V. and others
Defendant:
MSN Laboratories Private Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. et al v. Aurobindo Pharma Limited et al
as 1:2022cv00377
Plaintiff:
MSD International Business GmbH, MSD International GmbH, Pfizer Inc. and others
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
